Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by letsdoiton Feb 16, 2021 1:42pm
125 Views
Post# 32574944

RE: No sales, no profit, no FDA, NO mfg

RE: No sales, no profit, no FDA, NO mfgHere we are at the end of February and not one sale which means no profit, no manufacturer announced, no FDA approval just promises, promises and more promises, no update whatsoever on the Upenn and Hitchcock freebies and now I'm starting to think that these PO's were a stunt pulled off by management to keep the SP artificially inflated and to throw the shareholders off the scent that the there are major, catastrophic flaws with the machine, it's pretty obvious to me that there are issues, complete silence from these (alleged) sales which happened 3 months ago now, don't you find that very, very strange? I do
<< Previous
Bullboard Posts
Next >>